Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam

Inclusion Criteria: * Healthy male or female volunteer aged 18 to 50 years inclusive * Body Mass Index (BMI) between 18.0 and 30.0 kg/m² inclusive * Good physical and mental health status * Blood pressure and heart rate within normal range * Electrocardiogram and laboratory tests without clinically significant abnormality Exclusion Criteria: * IQ ≤ 80 as determined by Test of non-verbal intelligence * Center for Epidemiological Studies Depression (CES-D Scale ≥16, * Known allergy/intolerance to pyrrolidinone derivatives * Abnormalities on EEG recordings * Pregnant, lactating women * History or presence of cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrinological, neurological, psychiatric disorders * Use of any hepatic enzyme-inducing drug